{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:56:49Z","timestamp":1786665409467,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["13-0042"],"award-info":[{"award-number":["13-0042"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["16-0119"],"award-info":[{"award-number":["16-0119"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["082828"],"award-info":[{"award-number":["082828"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["097828"],"award-info":[{"award-number":["097828"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1362\/A180081"],"award-info":[{"award-number":["C1362\/A180081"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,2,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumour suppressor BRCA1-associated protein 1 (BAP1) is the most frequently mutated cancer gene in mesothelioma. Here we report novel functions for BAP1 in mitotic progression highlighting the relationship between BAP1 and control of genome stability in mesothelioma cells with therapeutic implications. Depletion of BAP1 protein induced proteasome-mediated degradation of BRCA1 in mesothelioma cells while loss of BAP1 correlated with BRCA1 loss in mesothelioma patient tumour samples. BAP1 loss also led to mitotic defects that phenocopied the loss of BRCA1 including spindle assembly checkpoint failure, centrosome amplification and chromosome segregation errors. However, loss of BAP1 also led to additional mitotic changes that were not observed upon BRCA1 loss, including an increase in spindle length and enhanced growth of astral microtubules. Intriguingly, these consequences could be explained by loss of expression of the KIF18A and KIF18B kinesin motors that occurred upon depletion of BAP1 but not BRCA1, as spindle and astral microtubule defects were rescued by re-expression of KIF18A and KIF18B, respectively. We therefore propose that BAP1 inactivation causes mitotic defects through BRCA1-dependent and independent mechanisms revealing novel routes by which mesothelioma cells lacking BAP1 may acquire genome instability and exhibit altered responses to microtubule-targeted agents.<\/jats:p>","DOI":"10.1038\/s41388-022-02577-3","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T13:02:59Z","timestamp":1671714179000},"page":"572-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms"],"prefix":"10.1038","volume":"42","author":[{"given":"Anita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Busacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Gaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sheaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Poile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Nakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Dzialo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Bzura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-1312","authenticated-orcid":false,"given":"Dean A.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-7329","authenticated-orcid":false,"given":"Andrew M.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2577_CR1","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMra1912719","volume":"385","author":"SM Janes","year":"2021","unstructured":"Janes SM, Alrifai D, Fennell DA. Perpsectives on the treatment of malignant pleural mesothelioma. N Engl J Med. 2021;385:1207\u201318.","journal-title":"N Engl J Med"},{"key":"2577_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak AK, Fujimoto N, Peters S, Tsao AS, et al. First-line nivolumab pus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): A multicentre, randomised, open-label, phase 3 trial. Lancet. 2021;397:375\u201386.","journal-title":"Lancet"},{"key":"2577_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/S1470-2045(21)00471-X","volume":"22","author":"DA Fennell","year":"2021","unstructured":"Fennell DA, Ewings S, Ottensmeier C, Califano R, Hanna GG, Hill K, et al. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): A multicentre, double-blind, randomised, phase 3 trial. Lancet Oncol. 2021;22:1530\u201340.","journal-title":"Lancet Oncol"},{"key":"2577_CR4","doi-asserted-by":"publisher","first-page":"101432","DOI":"10.1016\/j.eclinm.2022.101432","volume":"48","author":"DA Fennell","year":"2022","unstructured":"Fennell DA, Porter C, Lester J, Danson S, Taylor P, Sheaff M, et al. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. EClinicalMedicine. 2022;48:101432.","journal-title":"EClinicalMedicine"},{"key":"2577_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48:407\u201316.","journal-title":"Nat Genet"},{"key":"2577_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, et al. Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Disco. 2020;10:1103\u201320.","journal-title":"Cancer Disco"},{"key":"2577_CR7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","volume":"8","author":"J Hmeljak","year":"2018","unstructured":"Hmeljak J, Sanchez-Vega F, Hoadley KA, Shih J, Stewart C, Heiman D, et al. Integrative molecular characterization of malignant pleural mesothelioma. Cancer Disco. 2018;8:1548\u201365.","journal-title":"Cancer Disco"},{"key":"2577_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10:565\u201376.","journal-title":"J Thorac Oncol"},{"key":"2577_CR9","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1073\/pnas.1612074113","volume":"113","author":"Y Yoshikawa","year":"2016","unstructured":"Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proc Natl Acad Sci USA. 2016;113:13432\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2577_CR10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","volume":"28","author":"J Andrici","year":"2015","unstructured":"Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, et al. Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Mod Pathol. 2015;28:1360\u20138.","journal-title":"Mod Pathol"},{"key":"2577_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep18462","volume":"5","author":"S Bhattacharya","year":"2015","unstructured":"Bhattacharya S, Hanpude P, Maiti TK. Cancer associated missense mutations in BAP catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation. Sci Rep. 2015;5:18462.","journal-title":"Sci Rep"},{"key":"2577_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.1381306","volume":"20","author":"RA Greenberg","year":"2006","unstructured":"Greenberg RA, Sobhian B, Pathania S, Cantor SB, Nakatani Y, Livingston DM. Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes. Genes Dev. 2006;20:34\u201346.","journal-title":"Genes Dev"},{"key":"2577_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.exphem.2015.04.013","volume":"43","author":"F Dkhissi","year":"2015","unstructured":"Dkhissi F, Aggoune D, Pontis J, Sorel N, Piccirilli N, LeCorf A, et al. The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia. Exp Hematol. 2015;43:775\u201380.","journal-title":"Exp Hematol"},{"key":"2577_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/cas.12698","volume":"106","author":"S Hakiri","year":"2015","unstructured":"Hakiri S, Osada H, Ishiguro F, Murakami H, Murakami-Tonami Y, Yokoi K, et al. Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells. Cancer Sci. 2015;106:990\u20139.","journal-title":"Cancer Sci"},{"key":"2577_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","volume":"69","author":"H Nishikawa","year":"2009","unstructured":"Nishikawa H, Wu W, Koike A, Kojima R, Gomi H, Fukuda M, et al. BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity. Cancer Res. 2009;69:111\u20139.","journal-title":"Cancer Res"},{"key":"2577_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, Adusumilli PS, Alexander R, Baas P, Bardelli F, Bononi A, et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69:402\u201329.","journal-title":"CA Cancer J Clin"},{"key":"2577_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-020-0265-y","volume":"20","author":"M Carbone","year":"2020","unstructured":"Carbone M, Arron ST, Beutler B, Bononi A, Cavenee W, Cleaver JE, et al. Tumour predisposition and cancer syndromes as models to study gene-environment interactions. Nat Rev Cancer. 2020;20:533\u201349.","journal-title":"Nat Rev Cancer"},{"key":"2577_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature22798","volume":"546","author":"A Bononi","year":"2017","unstructured":"Bononi A, Giorgi C, Patergnani S, Larson D, Verbruggen K, Tanji M, et al. BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation. Nature. 2017;546:549\u201353.","journal-title":"Nature"},{"key":"2577_CR19","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/cdd.2017.95","volume":"24","author":"A Bononi","year":"2017","unstructured":"Bononi A, Yang H, Giorgi C, Patergnani S, Pellegrini L, Su M, et al. Germline BAP1 mutations induce a Warburg effect. Cell Death Diff. 2017;24:1694\u2013704.","journal-title":"Cell Death Diff"},{"key":"2577_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer. 2013;13:153\u20139.","journal-title":"Nat Rev Cancer"},{"key":"2577_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BST20160173","volume":"45","author":"EC Chittock","year":"2017","unstructured":"Chittock EC, Latwiel S, Miller TC, Muller CW. Molecular architecture of polycomb repressive complexes. Biochem Soc Trans. 2017;45:193\u2013205.","journal-title":"Biochem Soc Trans"},{"key":"2577_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1568009615666151030102427","volume":"16","author":"T Fukuda","year":"2016","unstructured":"Fukuda T, Tsuruga T, Kuroda T, Nishikawa H, Ohta T. Functional Link between BRCA1 and BAP1 through Histone H2A, heterochromatin and DNA damage response. Curr Cancer Drug Targets. 2016;16:101\u20139.","journal-title":"Curr Cancer Drug Targets"},{"key":"2577_CR23","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.3947","volume":"21","author":"LM LaFave","year":"2015","unstructured":"LaFave LM, Beguelin W, Koche R, Teater M, Spitzer B, Chramiec A, et al. Loss of BAP1 function leads to EZH2-dependent transformation. Nat Med. 2015;21:1344\u20139.","journal-title":"Nat Med"},{"key":"2577_CR24","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1128\/MCB.01517-08","volume":"29","author":"S Misaghi","year":"2009","unstructured":"Misaghi S, Ottosen S, Izrael-Tomasevic A, Arnott D, Lamkanfi M, Lee J, et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol Cell Biol. 2009;29:2181\u201392.","journal-title":"Mol Cell Biol"},{"key":"2577_CR25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1074\/jbc.M114.609834","volume":"290","author":"Y Okino","year":"2015","unstructured":"Okino Y, Machida Y, Frankland-Searby S, Machida YJ. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes. J Biol Chem. 2015;290:1580\u201391.","journal-title":"J Biol Chem"},{"key":"2577_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10292","volume":"7","author":"DD Sahtoe","year":"2016","unstructured":"Sahtoe DD, van Dijk WJ, Ekkebus R, Ovaa H, Sixma TK. BAP1\/ASXL1 recruitment and activation for H2A deubiquitination. Nat Commun. 2016;7:10292.","journal-title":"Nat Commun"},{"key":"2577_CR27","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1128\/MCB.00396-10","volume":"30","author":"H Yu","year":"2010","unstructured":"Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G, et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol. 2010;30:5071\u201385.","journal-title":"Mol Cell Biol"},{"key":"2577_CR28","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/ijc.23665","volume":"123","author":"A Erez","year":"2008","unstructured":"Erez A, Chaussepied M, Castiel A, Colaizzo-Anas T, Aplan PD, Ginsberg D, et al. The mitotic checkpoint gene, SIL is regulated by E2F1. Int J Cancer. 2008;123:1721\u20135.","journal-title":"Int J Cancer"},{"key":"2577_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.onc.1209028","volume":"25","author":"MJ Ko","year":"2006","unstructured":"Ko MJ, Murata K, Hwang DS, Parvin JD. Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle. Oncogene. 2006;25:298\u2013303.","journal-title":"Oncogene"},{"key":"2577_CR30","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1128\/MCB.25.19.8656-8668.2005","volume":"25","author":"S Sankaran","year":"2005","unstructured":"Sankaran S, Starita LM, Groen AC, Ko MJ, Parvin JD. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol. 2005;25:8656\u201368.","journal-title":"Mol Cell Biol"},{"key":"2577_CR31","doi-asserted-by":"publisher","first-page":"8457","DOI":"10.1128\/MCB.24.19.8457-8466.2004","volume":"24","author":"LM Starita","year":"2004","unstructured":"Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP, et al. BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol. 2004;24:8457\u201366.","journal-title":"Mol Cell Biol"},{"key":"2577_CR32","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1158\/0008-5472.CAN-14-0221","volume":"74","author":"R Zarrizi","year":"2014","unstructured":"Zarrizi R, Menard JA, Belting M, Massoumi R. Deubiquitination of gamma-tubulin by BAP1 prevents chromosome instability in breast cancer cells. Cancer Res. 2014;74:6499\u2013508.","journal-title":"Cancer Res"},{"key":"2577_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2015.08.013","volume":"369","author":"J Peng","year":"2015","unstructured":"Peng J, Ma J, Li W, Mo R, Zhang P, Gao K, et al. Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma. Cancer Lett. 2015;369:167\u201374.","journal-title":"Cancer Lett"},{"key":"2577_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/ncb2387","volume":"13","author":"S Petry","year":"2011","unstructured":"Petry S, Vale RD. A new cap for kinetochore fibre minus ends. Nat Cell Biol. 2011;13:1389\u201391.","journal-title":"Nat Cell Biol"},{"key":"2577_CR35","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1073\/pnas.0611132104","volume":"104","author":"V Trachana","year":"2007","unstructured":"Trachana V, Van Wely KHM, Guerrero AA, Futterer A, Martinez-A C. Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability. Proc Natl Acad Sci USA. 2007;104:2691\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2577_CR36","first-page":"1455","volume":"10","author":"J Xiao","year":"2020","unstructured":"Xiao J, Zhang R, Peng J, Yang Z. BAP1 maintains chromosome stability by stabilizing DIDO1 in renal cell carcinoma. Am J Cancer Res. 2020;10:1455\u201366.","journal-title":"Am J Cancer Res"},{"key":"2577_CR37","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","volume":"68","author":"KH Ventii","year":"2008","unstructured":"Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 2008;68:6953\u201362.","journal-title":"Cancer Res"},{"key":"2577_CR38","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","volume":"103","author":"Y Yoshikawa","year":"2012","unstructured":"Yoshikawa Y, Sato A, Tsujimura T, Emi M, Morinaga T, Fukuoka K, et al. Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci. 2012;103:868\u201374.","journal-title":"Cancer Sci"},{"key":"2577_CR39","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jtho.2016.06.020","volume":"11","author":"L Righi","year":"2016","unstructured":"Righi L, Duregon E, Vatrano S, Izzo S, Giorcelli J, Rondon-Lagos M, et al. BRCA1-Associated Protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: A large retrospective study. J Thorac Oncol. 2016;11:2006\u201317.","journal-title":"J Thorac Oncol"},{"key":"2577_CR40","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1083\/jcb.143.5.1329","volume":"143","author":"I Irminger-Finger","year":"1998","unstructured":"Irminger-Finger I, Soriano JV, Vaudan G, Montesano R, Sappino AP. In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells. J Cell Biol. 1998;143:1329\u201339.","journal-title":"J Cell Biol"},{"key":"2577_CR41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/cancers11081123","volume":"11","author":"A Pantelias","year":"2019","unstructured":"Pantelias A, Karachristou I, Georgakilas AG, Terzoudi GI. Interphase cytogenetic analysis of micronucleated and multinucleated cells supports the premature chromosome condensation hypothesis as the mechanistic origin of chromothripsis. Cancers. 2019;11:1123.","journal-title":"Cancers"},{"key":"2577_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/genes10050366","volume":"10","author":"CJ Ye","year":"2019","unstructured":"Ye CJ, Sharpe Z, Alemara S, Mackenzie S, Liu G, Abdallah B, et al. Micronuclei and genome chaos: Changing the system inheritance. Genes. 2019;10:366.","journal-title":"Genes"},{"key":"2577_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/jbiol195","volume":"8","author":"A Khodjakov","year":"2009","unstructured":"Khodjakov A, Rieder CL. The nature of cell-cycle checkpoints: facts and fallacies. J Biol. 2009;8:88.","journal-title":"J Biol"},{"key":"2577_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrm2163","volume":"8","author":"A Musacchio","year":"2007","unstructured":"Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol. 2007;8:379\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2577_CR45","doi-asserted-by":"publisher","first-page":"17108","DOI":"10.1073\/pnas.0407585101","volume":"101","author":"RH Wang","year":"2004","unstructured":"Wang RH, Yu H, Deng CX. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint. Proc Natl Acad Sci USA. 2004;101:17108\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2577_CR46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1097-2765(00)80466-9","volume":"3","author":"X Xu","year":"1999","unstructured":"Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell. 1999;3:389\u201395.","journal-title":"Mol Cell"},{"key":"2577_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature08136","volume":"460","author":"NJ Ganem","year":"2009","unstructured":"Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460:278\u201382.","journal-title":"Nature"},{"key":"2577_CR48","doi-asserted-by":"crossref","unstructured":"Godinho SA, Pellman D. Causes and consequences of centrosome abnormalities in cancer. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130467.","DOI":"10.1098\/rstb.2013.0467"},{"key":"2577_CR49","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/S0960-9822(95)00276-4","volume":"5","author":"SD Fuller","year":"1995","unstructured":"Fuller SD, Gowen BE, Reinsch S, Sawyer A, Buendia B, Wepf R, et al. The core of the mammalian centriole contains gamma-tubulin. Curr Biol. 1995;5:1384\u201393.","journal-title":"Curr Biol"},{"key":"2577_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1083\/jcb.200510028","volume":"172","author":"L Haren","year":"2006","unstructured":"Haren L, Remy MH, Bazin I, Callebaut I, Wright M, Merdes A. NEDD1-dependent recruitment of the gamma-tubulin ring complex to the centrosome is necessary for centriole duplication and spindle assembly. J Cell Biol. 2006;172:505\u201315.","journal-title":"J Cell Biol"},{"key":"2577_CR51","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1074\/jbc.M111.327296","volume":"287","author":"KM Brodie","year":"2012","unstructured":"Brodie KM, Henderson BR. Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase. J Biol Chem. 2012;287:7701\u201316.","journal-title":"J Biol Chem"},{"key":"2577_CR52","doi-asserted-by":"publisher","first-page":"12983","DOI":"10.1073\/pnas.95.22.12983","volume":"95","author":"L-C Hsu","year":"1998","unstructured":"Hsu L-C, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci USA. 1998;95:12983\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2577_CR53","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.4161\/cc.21396","volume":"11","author":"P Tarapore","year":"2012","unstructured":"Tarapore P, Hanashiro K, Fukasawa K. Analysis of centrosome localization of BRCA1 and its activity in suppressing centrosomal aster formation. Cell Cycle. 2012;11:2931\u201346.","journal-title":"Cell Cycle"},{"key":"2577_CR54","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.4161\/cbt.6.12.5164","volume":"6","author":"S Sankaran","year":"2007","unstructured":"Sankaran S, Crone DE, Palazzo RE, Parvin JD. BRCA1 regulates gamma-tubulin binding to centrosomes. Cancer Biol Ther. 2007;6:1853\u20137.","journal-title":"Cancer Biol Ther"},{"key":"2577_CR55","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/onc.2013.85","volume":"33","author":"M Sung","year":"2014","unstructured":"Sung M, Giannakakou P. BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling. Oncogene. 2014;33:1418\u201328.","journal-title":"Oncogene"},{"key":"2577_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1083\/jcb.200912163","volume":"189","author":"AR Barr","year":"2010","unstructured":"Barr AR, Kilmartin JV, Gergely F. CDK5RAP2 functions in centrosome to spindle pole attachment and DNA damage response. J Cell Biol. 2010;189:23\u201339.","journal-title":"J Cell Biol"},{"key":"2577_CR57","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1091\/mbc.e07-04-0371","volume":"19","author":"KW Fong","year":"2008","unstructured":"Fong KW, Choi YK, Rattner JB, Qi RZ. CDK5RAP2 is a pericentriolar protein that functions in centrosomal attachment of the gamma-tubulin ring complex. Mol Biol Cell. 2008;19:115\u201325.","journal-title":"Mol Biol Cell"},{"key":"2577_CR58","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1083\/jcb.201510015","volume":"211","author":"R Heald","year":"2015","unstructured":"Heald R, Khodjakov A. Thirty years of search and capture: The complex simplicity of mitotic spindle assembly. J Cell Biol. 2015;211:1103\u201311.","journal-title":"J Cell Biol"},{"key":"2577_CR59","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cub.2011.08.005","volume":"21","author":"LN Weaver","year":"2011","unstructured":"Weaver LN, Ems-McClung SC, Stout JR, LeBlanc C, Shaw SL, Gardner MK, et al. Kif18A uses a microtubule binding site in the tail for plus-end localization and spindle length regulation. Curr Biol. 2011;21:1500\u20136.","journal-title":"Curr Biol"},{"key":"2577_CR60","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1091\/mbc.e11-04-0363","volume":"22","author":"JR Stout","year":"2011","unstructured":"Stout JR, Yount AL, Powers JA, Leblanc C, Ems-McClung SC, Walczak CE. Kif18B interacts with EB1 and controls astral microtubule length during mitosis. Mol Biol Cell. 2011;22:3070\u201380.","journal-title":"Mol Biol Cell"},{"key":"2577_CR61","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.devcel.2007.11.014","volume":"14","author":"J Stumpff","year":"2008","unstructured":"Stumpff J, von Dassow G, Wagenbach M, Asbury C, Wordeman L. The kinesin-8 motor Kif18A suppresses kinetochore movements to control mitotic chromosome alignment. Dev Cell. 2008;14:252\u201362.","journal-title":"Dev Cell"},{"key":"2577_CR62","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.molcel.2011.07.022","volume":"43","author":"J Stumpff","year":"2011","unstructured":"Stumpff J, Du Y, English CA, Maliga Z, Wagenbach M, Asbury CL, et al. A tethering mechanism controls the processivity and kinetochore-microtubule plus-end enrichment of the kinesin-8 Kif18A. Mol Cell. 2011;43:764\u201375.","journal-title":"Mol Cell"},{"key":"2577_CR63","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1083\/jcb.201705209","volume":"217","author":"T McHugh","year":"2018","unstructured":"McHugh T, Gluszek AA, Welburn JPI. Microtubule end tethering of a processive kinesin-8 motor Kif18b is required for spindle positioning. J Cell Biol. 2018;217:2403\u201316.","journal-title":"J Cell Biol"},{"key":"2577_CR64","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1091\/mbc.e16-04-0254","volume":"27","author":"CE Walczak","year":"2016","unstructured":"Walczak CE, Zong H, Jain S, Stout JR. Spatial regulation of astral microtubule dynamics by Kif18B in PtK cells. Mol Biol Cell. 2016;27:3021\u201330.","journal-title":"Mol Biol Cell"},{"key":"2577_CR65","doi-asserted-by":"crossref","unstructured":"Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG et al. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford) 2016; baw100.","DOI":"10.1093\/database\/baw100"},{"key":"2577_CR66","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/onc.2011.217","volume":"31","author":"MH Lee","year":"2012","unstructured":"Lee MH, Lahusen T, Wang RH, Xiao C, Xu X, Hwang YS, et al. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation. Oncogene. 2012;31:116\u201327.","journal-title":"Oncogene"},{"key":"2577_CR67","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.bbrc.2014.01.075","volume":"444","author":"X Wang","year":"2014","unstructured":"Wang X, Lu G, Li L, Yi J, Yan K, Wang Y, et al. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway. Biochem Biophys Res Commun. 2014;444:549\u201354.","journal-title":"Biochem Biophys Res Commun"},{"key":"2577_CR68","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/path.3979","volume":"227","author":"S Busacca","year":"2012","unstructured":"Busacca S, Sheaff M, Arthur K, Gray SG, O\u2019Byrne KJ, Richard DJ, et al. BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma. J Pathol. 2012;227:200\u20138.","journal-title":"J Pathol"},{"key":"2577_CR69","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.molcel.2011.06.027","volume":"43","author":"X Su","year":"2011","unstructured":"Su X, Qiu W, Gupta ML Jr, Pereira-Leal JB, Reck-Peterson SL, Pellman D. Mechanisms underlying the dual-mode regulation of microtubule dynamics by Kip3\/kinesin-8. Mol Cell. 2011;43:751\u201363.","journal-title":"Mol Cell"},{"key":"2577_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5397","volume":"5","author":"J Hafner","year":"2014","unstructured":"Hafner J, Mayr MI, Mockel MM, Mayer TU. Pre-anaphase chromosome oscillations are regulated by the antagonistic activities of Cdk1 and PP1 on Kif18A. Nat Commun. 2014;5:4397.","journal-title":"Nat Commun"},{"key":"2577_CR71","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.cub.2018.06.026","volume":"28","author":"LME Janssen","year":"2018","unstructured":"Janssen LME, Averink TV, Blomen VA, Brummelkamp TR, Medema RH, Raaijmakers JA. Loss of Kif18A results in spindle assembly checkpoint activation at microtubule-attached kinetochores. Curr Biol. 2018;28:2685\u201396.e2684.","journal-title":"Curr Biol"},{"key":"2577_CR72","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cub.2007.02.036","volume":"17","author":"MI Mayr","year":"2007","unstructured":"Mayr MI, Hummer S, Bormann J, Gruner T, Adio S, Woehlke G, et al. The human kinesin Kif18A is a motile microtubule depolymerase essential for chromosome congression. Curr Biol. 2007;17:488\u201398.","journal-title":"Curr Biol"},{"key":"2577_CR73","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jcp.21525","volume":"217","author":"M Zusev","year":"2008","unstructured":"Zusev M, Benayahu D. New insights on cellular distribution, microtubule interactions and post-translational modifications of MS-KIF18A. J Cell Physiol. 2008;217:618\u201325.","journal-title":"J Cell Physiol"},{"key":"2577_CR74","doi-asserted-by":"publisher","first-page":"32944","DOI":"10.1074\/jbc.M503396200","volume":"280","author":"C Slawson","year":"2005","unstructured":"Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW. Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem. 2005;280:32944\u201356.","journal-title":"J Biol Chem"},{"key":"2577_CR75","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012;337:1541\u20136.","journal-title":"Science"},{"key":"2577_CR76","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/nar\/28.3.678","volume":"28","author":"PM Ajuh","year":"2000","unstructured":"Ajuh PM, Browne GJ, Hawkes NA, Cohen PT, Roberts SG, Lamond AI. Association of a protein phosphatase 1 activity with the human factor C1 (HCF) complex. Nucleic Acids Res. 2000;28:678\u201386.","journal-title":"Nucleic Acids Res"},{"key":"2577_CR77","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.lungcan.2018.12.004","volume":"127","author":"N Kumar","year":"2019","unstructured":"Kumar N, Alrifai D, Kolluri KK, Sage EK, Ishii Y, Guppy N, et al. Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma. Lung Cancer. 2019;127:164\u20136.","journal-title":"Lung Cancer"},{"key":"2577_CR78","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/path.2925","volume":"224","author":"I Paul","year":"2011","unstructured":"Paul I, Savage KI, Blayney JK, Lamers E, Gately K, Kerr K, et al. PARP inhibition induces BAX\/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer. J Pathol. 2011;224:564\u201374.","journal-title":"J Pathol"},{"key":"2577_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21798-w","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang M, Luo J-L, Sun Q, Harber J, Dawson AG, Nakas A, et al. Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment. Nat Commun. 2021;12:1751.","journal-title":"Nat Commun"},{"key":"2577_CR80","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1128\/MCB.01867-08","volume":"29","author":"L O\u2019Regan","year":"2009","unstructured":"O\u2019Regan L, Fry AM. The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis. Mol Cell Biol. 2009;29:3975\u201390.","journal-title":"Mol Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02577-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T05:21:07Z","timestamp":1676611267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02577-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,2,17]]}},"alternative-id":["2577"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02577-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1861945\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"15 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.A.F. reports grants from Astex Therapeutics, Boehringer Ingelheim, MSD and Bayer; personal fees from Aldeyra, Inventiva, RS Oncology, Roche, Atara, Targovax, Lab21 and BMS; and non-financial support from Clovis, Eli Lilly, Roche and BMS. All other authors declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}